C

Cardiology Associates of Fairfield County, P.C. | Stamford, CT

Research site
(Unclaimed)
Location
1177 Summer Street 5th Floor, Stamford, Connecticut, United States of America
Site insights

Top conditions

Obesity (2 trials)

Overweight (2 trials)

Cardiovascular Diseases (2 trials)

Diabetes Mellitus (1 trial)

Heart Failure (1 trial)

Top treatments

Tirzepatide
LY3298176
BELVIQ
Milvexian
Lorcaserin HCl

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Other: Placebo
Drug: Milvexian

The main purpose of this study is to assess the efficacy and safety of Tirzepatide (LY3298176) in participants with heart failure with preserved ejec...

Active, not recruiting
Heart Failure With Preserved Ejection Fraction
Obesity
Other: Placebo
Drug: Tirzepatide

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Lepodisiran Sodium
Drug: Placebo

Trial sponsors

Lilly logo

Lilly (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems